Researchers sought to develop and validate an MRI radiomics prediction model through a machine learning-based method to predict the survival of patients with glioma.
Researchers sought to evaluate the activity and safety of dabrafenib plus trametinib in adult patients with recurrent or progressive BRAF V600E -mutation–positive high-grade and low-grade glioma.
Researchers applied a machine learning strategy in a longitudinal analysis of clinical features linked to neurofibromatosis type 1 in pediatric patients.